Answers are grounded in this paper and cite their sources.
Gene therapy provides powerful new approaches to curing a large variety of diseases, which are being explored in ongoing worldwide clinical trials. To overcome the limitations of viral gene delivery systems, synthetic nonviral vectors such as cationic liposomes (CLs) are desirable. However, improvements of their efficiency at reduced toxicity and a better understanding of their mechanism of action are required. We present the efficient synthesis of a series of degradable multivalent cationic lipids (CMVLn, n = 2 to 5) containing a disulfide bond spacer between headgroup and lipophilic tails. This spacer is designed to be cleaved in the reducing milieu of the cytoplasm and thus decrease lipid toxicity. Small angle X-ray scattering demonstrates that the initially formed lamellar phase of CMVLn–DNA complexes completely disappears when reducing agents such as DTT or the biologically relevant reducing peptide glutathione are added to mimic the intracellular milieu. The CMVLs (n = 3 to 5) exhibit reduced cytotoxicity and transfect mammalian cells with efficiencies comparable to those of highly efficient non-degradable analogs and benchmark commercial reagents such as Lipofectamine 2000. Thus, our results demonstrate that degradable disulfide spacers may be used to reduce the cytotoxicity of synthetic nonviral gene delivery carriers without compromising their transfection efficiency. ► Synthesis of a series of degradable multivalent cationic lipids (CMVLs), 2+ to 5+ ► Disulfide spacer between head and tails is reductively cleaved in cytoplasm ► Triggered disintegration of disulfide spacers significantly reduces cytotoxicity ► Reductive cleavage disassembles CMVLn–DNA complexes ► CMVLs (3+ to 5+) transfect as efficiently as benchmark reagents
No takes yet. Share an insight, caveat, or question.
Shirazi et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: